Understanding the Market | MORIMATSU INTL rises over 9%, new orders signed in the first half exceed expectations, and the company will benefit from the release of overseas pharmaceutical momentum
I'm PortAI, I can summarize articles.
MORIMATSU INTL's stock price rose by more than 9%, with an increase of 9.38% as of the time of publication, trading at HKD 10.84, with a transaction volume of HKD 177 million. The company signed new orders worth RMB 5.996 billion in the first half of the year, a year-on-year increase of 89.5%, of which pharmaceutical orders amounted to RMB 4.372 billion, a year-on-year increase of 642%. The backlog of orders is RMB 10.566 billion, a year-on-year increase of 20.4%. Huatai Securities expects the company to resume double-digit net profit growth in the future
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments